Mixed Dyslipidemias Completed Phase Trials for Bempedoic acid (DB11936)
Also known as: Mixed Hyperlipidaemia / Mixed Dyslipidemia / Mixed Hyperlipidemia / Mixed hypercholesterolemia / Broad- or floating-betalipoproteinemia / Type V hyperlipidaemia / Type V hyperlipidemia / Type V lipidaemia / Type V lipidemia / Hyperlipoproteinemia Type V / Type V hyperlipoproteinemia / Fredrickson Type V lipidemia / Fredrickson Type V lipidaemia / Type V hyperlipoproteinaemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0073163 (Mixed Dyslipidemias) | Completed | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05546398 | SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Treat Patients at High and Very High Cardiovascular Risk With hyperchOlesterolemia or Mixed Dyslipidemia With NUSTENDI® |